Pharmadrug Inc. PHRX.CN Stock
Pharmadrug Inc. Price Chart
Pharmadrug Inc. PHRX.CN Financial and Trading Overview
Pharmadrug Inc. stock price | 0.03 CAD |
Previous Close | 0.005 CAD |
Open | 0 CAD |
Bid | 0.005 CAD x N/A |
Ask | 0.01 CAD x N/A |
Day's Range | 0 - 0 CAD |
52 Week Range | 0 - 0.04 CAD |
Volume | 0 CAD |
Avg. Volume | 410.7K CAD |
Market Cap | 1.78M CAD |
Beta (5Y Monthly) | 3.055428 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.23 CAD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PHRX.CN Valuation Measures
Enterprise Value | 2.95M CAD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.20833333 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -3.713 |
Trading Information
Pharmadrug Inc. Stock Price History
Beta (5Y Monthly) | 3.055428 |
52-Week Change | -83.33% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.04 CAD |
52 Week Low | 0 CAD |
50-Day Moving Average | 0.0083 CAD |
200-Day Moving Average | 0.02 CAD |
PHRX.CN Share Statistics
Avg. Volume (3 month) | 410.7K CAD |
Avg. Daily Volume (10-Days) | 215.77K CAD |
Shares Outstanding | 355.63M |
Float | 348.05M |
Short Ratio | 0.04 |
% Held by Insiders | 1.88% |
% Held by Institutions | 0% |
Shares Short | 18.41K |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.010% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -6.33% |
Return on Equity (ttm) | -13.58% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -795002 CAD |
Net Income Avi to Common (ttm) | -1628192 CAD |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 220.62K CAD |
Total Cash Per Share (mrq) | 0.001 CAD |
Total Debt (mrq) | 1.39M CAD |
Total Debt/Equity (mrq) | 16.11 CAD |
Current Ratio (mrq) | 0.539 |
Book Value Per Share (mrq) | 0.024 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1096925 CAD |
Levered Free Cash Flow (ttm) | -810520 CAD |
Profile of Pharmadrug Inc.
Country | Canada |
State | ON |
City | Toronto |
Address | 77 King Street West |
ZIP | M5K 1H1 |
Phone | N/A |
Website | https://www.pharmadrug.ca |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to vertically integrated elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. Further, the company also holds interest in Sairiyo Therapeutics Inc. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. is based in Toronto, Canada.
Q&A For Pharmadrug Inc. Stock
What is a current PHRX.CN stock price?
Pharmadrug Inc. PHRX.CN stock price today per share is 0.03 CAD.
How to purchase Pharmadrug Inc. stock?
You can buy PHRX.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmadrug Inc.?
The stock symbol or ticker of Pharmadrug Inc. is PHRX.CN.
Which industry does the Pharmadrug Inc. company belong to?
The Pharmadrug Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Pharmadrug Inc. have in circulation?
The max supply of Pharmadrug Inc. shares is 104.69M.
What is Pharmadrug Inc. Price to Earnings Ratio (PE Ratio)?
Pharmadrug Inc. PE Ratio is now.
What was Pharmadrug Inc. earnings per share over the trailing 12 months (TTM)?
Pharmadrug Inc. EPS is -0.23 CAD over the trailing 12 months.
Which sector does the Pharmadrug Inc. company belong to?
The Pharmadrug Inc. sector is Healthcare.